US Material Events SEC 8-K Filings — April 27, 2026

27-04-2026

Booz Allen Hamilton announced senior leadership changes effective May 2026 to bolster its advanced technology position: Troy Lahr appointed EVP and CFO effective May 4, reporting to CEO Horacio Rozanski; Kristine Martin Anderson elevated to President alongside her COO role effective May 1; Shannon Fitzgerald promoted to President of Civil Sector; and Richard Crowe to Chief Growth Officer. These moves highlight internal promotions and external hires with deep experience in finance, operations, and growth. The company employs approximately 31,600 people globally as of December 31, 2025, with $12.0 billion in revenue for the 12 months ended March 31, 2025.

• ·Troy Lahr brings over 25 years of experience, most recently as CFO at Sierra Space and previously CFO of Boeing’s Defense, Space & Security business.
• ·Kristine Martin Anderson has been a leader at Booz Allen for 20 years, becoming COO in 2022 after leading the Civil Sector business.
• ·Lahr began career with over a decade in investment banking at Stifel as an aerospace and defense equity analyst.

27-04-2026

Aerkomm Taiwan Inc., a subsidiary of Aerkomm Inc. (AKOM), entered into a Merger Agreement with Ejectt Inc. on or about April 27, 2026, under which Aerkomm Taiwan will absorb Ejectt via a 1:1 share exchange ratio, issuing 65,113,314 new shares valued at NT$651,133,140 to Ejectt shareholders. Post-merger, Aerkomm Taiwan's paid-in capital will increase to NT$1,151,133,140 with 115,113,314 issued shares, aimed at enhancing operational efficiency and resource integration. The tentative merger record date is June 27, 2024, subject to shareholder approval on May 23, 2024, and creditor objections within 30 days.

• ·Financial statements audited as of December 31, 2023; independent fairness opinion dated April 29, 2024.
• ·Creditor objection period: not less than 30 days post-board approval and public announcement.
• ·Merger effective upon shareholder approval at extraordinary meeting on May 23, 2024.
• ·All Ejectt assets, liabilities, rights, and obligations succeed to Aerkomm Taiwan on merger record date.
• ·Ejectt employees to receive employment offers recognizing prior service years.

27-04-2026

Meridian Corporation (NASDAQ: MRBK) announced the appointment of Ken Warriner to its Board of Directors and the board of its principal subsidiary, Meridian Bank, effective immediately on April 27, 2026. Warriner, Senior Director of Finance and Administration at the Naples Airport Authority since 2018, brings 16 years of healthcare finance experience and prior public accounting at PricewaterhouseCoopers, along with service on Meridian’s Advisory Council since 2022. Chairman Christopher J. Annas praised Warriner’s financial leadership, operational oversight, and strategic planning expertise as assets for delivering long-term shareholder value.

• ·Warriner began aviation career at Naples Airport Authority in 2018 and oversees accounting, IT, procurement, risk management, and investments
• ·Prior to NAA, 16 years in healthcare as Assistant Corporate Controller and CFO for hospitals in Florida and Mississippi
• ·Licensed Certified Public Accountant with degree from Baylor University
• ·Meridian Bank serves Pennsylvania, New Jersey, Delaware, Maryland, and Florida with business lending, real estate lending, electronic payments, and wealth management

27-04-2026

Crane Company (NYSE: CR) announced the completion of its previously disclosed CEO succession plan effective April 27, 2026, with Alex Alcala assuming the role of President and Chief Executive Officer, succeeding Max Mitchell who transitioned to Executive Chairman. Alcala brings 13 years of experience at Crane, having contributed to strategy, portfolio strengthening, and execution. The transition was described as seamless, with the company positioned for future growth under Alcala's leadership.

• ·Company founded in 1855.
• ·Focused on aerospace, defense, space, and process industry end markets.

27-04-2026

Sun Pharmaceutical Industries Limited has signed a definitive agreement to acquire all outstanding shares of Organon & Co. for $14.00 per share in cash, implying an enterprise value of $11.75 billion. The transaction positions the combined entity among the top 25 global pharmaceutical companies with $12.4 billion in revenue, strengthens Sun Pharma's women's health and biosimilars portfolios, and is expected to nearly double EBITDA and cash flow, though post-transaction Net Debt/EBITDA stands at 2.3x. The deal awaits regulatory approvals and Organon stockholder approval, with closure anticipated in early 2027 amid risks such as potential delays, competing bids, or failure to consummate.

• ·Transaction to be funded by Sun Pharma's cash resources and bank financing.
• ·Organon portfolio includes over 70 products commercialized in 140 countries.
• ·Combined company presence in 150 countries, with 18 large markets each over $100M revenue.
• ·Advisors: J.P. Morgan and Jefferies (Sun Pharma financial), Morgan Stanley and Goldman Sachs (Organon financial).

27-04-2026

On April 22, 2026, GAMCO Natural Resources, Gold & Income Trust (NYSE: GNT) entered into a Sales Agreement with G.research, LLC to offer and sell up to 1,000,000 common shares of beneficial interest at-the-market, with a minimum price not less than the current net asset value per share plus commission. The offering commenced on April 24, 2026, pursuant to a prospectus supplement dated April 24, 2026, and an accompanying prospectus dated February 5, 2024, under effective shelf registration statement Form N-2 (File No. 333-276020). No shares have been sold yet, and the agreement enables flexible capital raising without specified financial impact.

• ·Common shares par value $0.001 per share
• ·Securities registered on New York Stock Exchange under symbols GNT and GNT Pr A
• ·Registration Statement File No. 333-276020

27-04-2026

Driven Brands Holdings Inc.'s indirect wholly-owned subsidiaries, Driven Holdings Parent LLC and Driven Holdings, LLC, entered into a Fourth Amendment and limited waiver to their revolving credit facility under the Credit Agreement on April 24, 2026. The amendment waives any potential defaults from the intent to restate financial statements for fiscal years ending December 30, 2023, December 28, 2024, and the first three quarters of the fiscal year ending December 27, 2025, while extending the delivery deadline for FY2025 financials to June 10, 2026, and Q1 2026 financials to 45 days thereafter. This signals ongoing financial reporting challenges with no positive operational metrics disclosed.

• ·Fiscal quarters to restate: first three quarters of fiscal year ending December 27, 2025.
• ·Q1 2026 fiscal quarter ends March 28, 2026.
• ·Credit Agreement originally dated May 27, 2021.

27-04-2026

On April 20, 2026, Suncrete, Inc. increased its Board of Directors from seven to nine members, appointing Charles Owens as a Class I director (term expiring 2027) and Noreen Skelly as a Class II director (term expiring 2028), both joining the Audit Committee with Skelly as Chair. Owens brings extensive construction industry experience as a founder and former CEO of Construction Partners, Inc. (ROAD), while Skelly offers deep financial expertise as CFO of Blue Sky Bank and former CFO roles at multiple banks. The Board also granted restricted stock awards totaling 528,000 shares (96,000 Class A, 432,000 Class B) to eight non-employee directors under the 2026 Omnibus Incentive Plan as board service compensation.

• ·Restricted stock vests two-thirds on second anniversary and one-third on third anniversary of April 20, 2026 grant date, subject to continued service.
• ·New directors determined independent under SEC and Nasdaq rules; no arrangements or material interests under Item 404(a) of Regulation S-K.
• ·Director Grants issued under Section 4(a)(2) and/or Regulation D exemption from Securities Act registration.

27-04-2026

Oppenheimer Holdings Inc. (OPY) agreed to a $70 million settlement of the 'Cash Sweep' class action litigation filed in June 2025, avoiding a jury trial where plaintiffs sought over $440 million in damages based on discovery assertions. The settlement, subject to District Court approval within up to 90 days and formal documentation within 60 days, provides a full release of claims without admission of liability and is fully tax-deductible, but will significantly impact Q1 2026 earnings despite competitive rates during the disputed period from 2022. Class certification was granted on December 8, 2025, with trial set for June 2026.

• ·Litigation: Liberty Capital Group v. Oppenheimer Holdings Inc., et al., No. 1:25-cv04822-JSR, U.S. District Court Southern District of New York
• ·Company headquartered in New York with institutional businesses in London, Tel Aviv, and Hong Kong
• ·Earnings release expected May 1, 2026; Form 10-Q for quarter ended March 31, 2026 filed around same time

27-04-2026

SiteOne Landscape Supply, through its subsidiaries SiteOne Landscape Supply Holding, LLC and SiteOne Landscape Supply, LLC, entered into the First Amendment to the Amended and Restated Credit Agreement dated July 22, 2022, on April 22, 2026. The amendment facilitates the exit of certain Exiting Lenders, entry of New Lenders, reallocation of commitments among Existing and New Lenders, and prepayment of existing loans with new revolving credit loans upon the First Amendment Effective Date. No specific changes to commitment amounts or financial terms are detailed in the filing, with schedules amended but not quantified here.

• ·Original Credit Agreement dated July 22, 2022
• ·Fee Letter dated March 9, 2026
• ·Effectiveness subject to execution by Lenders representing 100% of Commitments, guarantor consents, certificates, representations and warranties, no Default, legal opinion, and payment of fees/expenses

27-04-2026

Auddia Inc. commenced a public offering on April 24, 2026, issuing 1,405,006 shares of common stock, pre-funded warrants to purchase 3,679,737 shares, and common warrants to purchase 5,084,743 shares at $2.36 per unit (or $2.359 per pre-funded unit), expected to generate approximately $12 million in gross proceeds and $10.9 million in net proceeds after fees. The net proceeds will fund working capital and general corporate purposes, with Dawson James Securities, Inc. as placement agent receiving a 7.0% cash fee and a 90-day lock-up on new share issuances imposed. Common warrants expire upon the pending merger with McCarthy Finney, Inc. (announced February 17, 2026) or five years from exercise.

• ·Pre-funded warrants immediately exercisable with $0.001 exercise price.
• ·Common warrants immediately exercisable at $2.36, adjustable downward by board, expire on merger closing or 5 years from initial exercise.
• ·Ownership limits prevent beneficial ownership exceeding 4.99% or 9.99% post-exercise.
• ·Offering pursuant to S-1 Registration Statement (No. 333-294887) effective April 23, 2026.

27-04-2026

Fulcrum Therapeutics reported positive Phase 1b PIONEER trial data for pociredir showing robust HbF induction, hemolysis/anemia improvements, and VOC reduction trends, with plans to initiate a potential registration-enabling trial in H2 2026 and cash of $333.3M supporting runway into 2029. However, Q1 2026 net loss widened 7% YoY to $18.9M, driven by R&D expenses up 5% to $14.1M and G&A up 16% to $8.1M, while cash decreased $19.0M QoQ to $333.3M. The company appointed Josh Lehrer to its Board and announced CFO Alan Musso's retirement later in 2026.

• ·Dosed first patient in open-label long-term dosing trial for pociredir.
• ·PIONEER trial abstract accepted for oral presentation at Foundation for Sickle Cell Disease Research Symposium in June 2026.
• ·Working capital of $328.8M as of March 31, 2026, down from $344.4M as of December 31, 2025.
• ·Pociredir granted Fast Track and Orphan Drug Designation from FDA for SCD.

27-04-2026

U.S. Energy Corp. (NASDAQ: USEG) executed a five-year, 100% take-or-pay helium offtake agreement with an unnamed investment-grade global industrial gas company for up to 1.2 MMCF per month (14.4 MMCF annually) from its Big Sky Carbon Hub at a fixed $285/MCF plant-gate price, with annual CPI-linked escalation starting March 1, 2028. The deal fully contracts Phase 1 helium volumes, supporting commercial operations targeted for Q1 2027 and de-risking the project alongside a recently expanded senior secured credit facility. No declines or flat metrics reported; the agreement positions helium as the initial contracted revenue stream in a multi-revenue platform including carbon management.

• ·Five-year initial term with year-three price redetermination option
• ·Phase 1 commercial operations targeted for Q1 2027; Phase 2 expected 2029 with 2-3x processing capacity
• ·Counterparty assumes all transportation, processing, and downstream costs
• ·EPA MRV plan approvals anticipated summer 2026
• ·Expanded senior secured credit facility closed April 20, 2026

27-04-2026

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) announced the appointment of Daniel B. Gilmer, Ph.D., a biopharmaceutical commercial executive and current Senior Director at Pfizer Inc., to its Board of Directors, effective April 24, 2026. Dr. Gilmer brings extensive experience in commercial launches, including leading the U.S. rollout of PAXLOVID and co-inventing Exebacase (CF-301/PlySs2), a bacteriophage lysin that received FDA Fast Track and Breakthrough Therapy designations. The appointment aims to bolster Armata's efforts to commercialize its pathogen-specific bacteriophage therapeutics for antibiotic-resistant infections.

• ·Dr. Gilmer joined Pfizer in May 2019; led U.S. PAXLOVID launch after FDA New Drug Approval.
• ·Previously at Pfizer: Antiviral and Diagnostics Business (Apr 2022-Feb 2025), Inflammation & Immunology (Apr 2021-Apr 2022).
• ·Ph.D. in Microbiology from Rockefeller University; B.S. from Howard University.
• ·Serves on Rockefeller University Board of Trustees Educational Affairs Committee and Ford Center Incubator selection committee.
• ·Member of New York Academy of Sciences and term member at Council on Foreign Relations.

27-04-2026

On April 23, 2026, the Board of Directors of Miami International Holdings, Inc. elected Eric Sites as a director to fill an existing vacancy, effective April 24, 2026, until the 2026 Annual Meeting of Shareholders or until his successor is elected and qualified. Mr. Sites has not been appointed to any Board committees and will receive standard non-employee director compensation, with no family relationships, related transactions, or arrangements disclosed regarding his election. He has entered into a standard indemnification agreement with the Company.

27-04-2026

Miluna Acquisition Corp (NASDAQ: MMTX), a SPAC that raised $69M in its October 2025 IPO, entered a definitive business combination agreement with CADV Ventures S.A. (CADV.AI), valuing CADV.AI at a $300M pre-money equity value (at $10/share), with an implied pro forma enterprise value of $408M for the combined Kukugan Corp. assuming no redemptions. CADV.AI shareholders will roll 100% equity and be eligible for up to 5M earnout shares upon revenue milestones; the deal includes potential PIPE/ELOC financing and is expected to close in H2 2026, led by CADV.AI's management including CEO Shang Ju Lin.

• ·CADV.AI founded in 2017, headquartered in Warsaw, Poland.
• ·Miluna formed in 2025, units/shares/warrants listed on Nasdaq as MMTXU/MMTX/MMTXW.
• ·Closing subject to Miluna shareholder approval, regulatory approvals, exchange listing, and customary conditions.

27-04-2026

AIG announced the completion of its planned CEO transition plan, with Eric Andersen becoming President and Chief Executive Officer and joining the Board of Directors effective June 1, 2026, while Peter Zaffino transitions to Executive Chair of the AIG Board. Leadership changes were praised for positioning AIG as a global leader with strong momentum from prior transformations. Further commentary will be provided during AIG’s Q1 2026 earnings call on May 1, 2026.

• ·Eric Andersen joined AIG in February 2026 as President and CEO-Elect.
• ·Q1 2026 earnings conference call scheduled for May 1, 2026, at 8:30 a.m. ET, with live webcast and replay available on www.aig.com.
• ·AIG (NYSE: AIG) is a leading global insurance organization.

27-04-2026

Avient Corporation announced the resignation of Jamie A. Beggs as Senior Vice President and Chief Financial Officer, effective June 1, 2026, to pursue other professional opportunities, with no disagreements on company matters. The Board appointed internal executive Giuseppe (Joe) Di Salvo, age 48, as the new Senior Vice President and Chief Financial Officer effective the same date. Di Salvo's package includes a $560,000 annual base salary and a one-time $220,000 RSU grant vesting over three years.

• ·Resignation notified on April 22, 2026; appointment by Board on April 24, 2026.
• ·Di Salvo previously served as Corporate Controller (2013-2018), VP Investor Relations, and led Treasury and FP&A since 2019.
• ·Severance under Executive Severance Plan: two years salary continuation, pro-rated incentive, and benefits if terminated without cause (non-change in control).
• ·Change-in-control Continuity Agreement provides lump-sum severance of two years base salary and target incentive if terminated within 24 months post-change in control.

27-04-2026

BioMarin Pharmaceutical Inc. completed its acquisition of Amicus Therapeutics for $14.50 per share in an all-cash transaction valued at approximately $4.8 billion, adding Galafold (migalastat) for Fabry disease, Pombiliti (cipaglucosidase alfa-atga) + Opfolda (miglustat) for Pompe disease, and U.S. rights to DMX-200 (Phase 3 for FSGS) to its portfolio. The deal strengthens BioMarin's rare disease focus with global commercial infrastructure. BioMarin expects to provide updated FY 2026 guidance on its Q1 earnings call on May 4, 2026; forward-looking statements highlight integration and regulatory risks.

• ·Galafold approved in more than 40 countries including U.S., EU, U.K., and Japan.
• ·BioMarin founded in 1997, based in San Rafael, California.

27-04-2026

Focus Universal Inc. (FCUV) filed an 8-K on April 27, 2026, reporting entry into a material definitive agreement (Item 1.01), completion of an acquisition or disposition of assets (Item 2.01), creation of a direct financial obligation (Item 2.03), and financial statements/exhibits (Item 9.01). Exhibit 99.1 provides Los Angeles County Assessors' 2026 assessment values for certain parcels, indicating involvement of real property in the transaction. No specific financial performance metrics, positive or negative changes, were disclosed in the provided content.

• ·Filing items: 1.01, 2.01, 2.03, 9.01
• ·Subcategory: Material Agreement Entry
• ·Exhibit: EX-99.1 (focus_ex9901.htm) detailing 2026 assessment values of parcels

27-04-2026

Abbott Laboratories amended and restated its By-Laws, effective April 24, 2026, originally adopted in 1963. The updated By-Laws specify the principal office location in Lake County, Illinois, and outline procedures for annual shareholder meetings, including election of directors and transaction of business. They impose detailed and stringent requirements for shareholder nominations and proposals, mandating timely written notices 90-120 days prior to the anniversary of the prior annual meeting, with updates and supplements as needed.

• ·Principal office: intersection of State Routes 43 and 137, Lake County, Illinois.
• ·Shareholder notice timeliness: not later than 90th day nor earlier than 120th day prior to prior annual meeting anniversary; adjusted if meeting date shifts by more than 30-60 days.
• ·Notice updates required as of record date and 10 business days prior to meeting.
• ·References Exchange Act rules including Rule 14a-8, Schedule 13D, 13F, 13G.

27-04-2026

Columbia Financial, Inc. entered into new two-year employment agreements effective April 1, 2026, with five senior executives—Dennis E. Gibney, Allyson Schlesinger, John Klimowich, Oliver E. Lewis, Jr., and Manesh Prabhu—replacing prior agreements and including annual base salaries for 2026 ranging from $430,000 to $700,000, eligibility for incentive plans, equity awards, and fringe benefits. The agreements feature automatic annual extensions unless notice is given 60 days prior, post-employment restrictive covenants, and severance provisions including 2x (base salary + target bonus) for termination without cause, escalating to 3x upon a change in control. No performance declines or negative metrics are reported in this governance-focused filing.

• ·Agreements entered into on April 21-22, 2026; initial term two years with auto-extension by 12 months each April 1 starting 2027 unless 60-day notice.
• ·Severance for termination without cause: 2x (base salary + target bonus); for disability/death: 1x (base salary + target bonus).
• ·Change in control severance within 24 months: 3x (base salary + target bonus) plus prior year bonus and 36 months health coverage subsidy.
• ·Restrictive covenants: 24-month non-solicitation/non-competition, perpetual confidentiality, mutual non-disparagement.

27-04-2026

Morgan Stanley Direct Lending Fund entered into the First Amendment to its Amended and Restated Senior Secured Revolving Credit Agreement, originally dated February 25, 2025, effective April 23, 2026, with Truist Bank as Administrative Agent and multiple lenders party thereto. The amended facility provides commitments totaling $1,450,000,000. Subsidiary guarantors DLF SPV LLC, DLF CA SPV LLC, and DLF Equity Holdings LLC reaffirmed their guarantees and security interests, with representations confirming no Defaults or Events of Default.

• ·Amendment amends the Credit Agreement by deleting stricken text and adding double-underlined text as per Exhibit A, and restates Schedules in Exhibit B.
• ·Conditions precedent include signed counterparts, legal opinion from Dechert LLP, organizational documents, and payment of invoiced fees.
• ·Governed by New York law; no waiver of existing rights.

27-04-2026

Riot Platforms, Inc. entered into a Second Amended and Restated Credit Agreement dated as of April 21, 2026, with Coinbase Credit, Inc. as Lender, Collateral Agent, and Administrative Agent, providing for a U.S.$200,000,000 credit facility collateralized by Bitcoin. This amends and restates the prior Existing Credit Agreement originally dated April 22, 2025. The agreement includes terms for borrowings, collateral adjustments based on LTV ratios, and events of default.

• ·Collateral Account: account number [***] with Coinbase Custody Trust Company, LLC.
• ·Availability Period: from Original Signing Date to three months after.
• ·Prior agreements: Original Credit Agreement (April 22, 2025), Existing Credit Agreement (First Amendment and Restatement Effective Date).

27-04-2026

Patrick R. Gruber retired as Chief Executive Officer of Gevo, Inc. on April 1, 2026. On April 22, 2026, the company entered into a Consulting Services Agreement with Patrick Gruber LLC (owned by Dr. Gruber), effective May 1, 2026, under which the consultant will provide transitional services until March 31, 2029, for a monthly fee of $30,000. The agreement includes customary provisions on confidentiality, work product ownership, and indemnification, and is subject to earlier termination by the company for cause or upon Dr. Gruber's death.

• ·Consulting Agreement filed as Exhibit 10.1
• ·Agreement dated April 22, 2026, with effective date of May 1, 2026

27-04-2026

Stanley Black & Decker, Inc. held its 2026 Annual Meeting of Shareholders on April 24, 2026, where all 10 director nominees were elected with strong support (122.8M-124.8M For votes out of 155.3M outstanding shares). Shareholders approved the Amended and Restated 2024 Omnibus Award Plan (120.2M For), advisory say-on-pay (122.0M For), and Ernst & Young LLP as auditor (134.1M For). However, a shareholder proposal for an independent board chairman failed overwhelmingly (10.5M For vs. 114.5M Against).

• ·Record date for meeting: February 25, 2026
• ·Board approved Amended Plan on February 24, 2026
• ·Fungible ratio adjusted to 2.71 for awards after effectiveness
• ·One-year minimum vesting period added to Amended Plan, subject to exceptions

27-04-2026

Domino’s Pizza, Inc. appointed Brian J. Pangburn, age 41, as Vice President—Controller and principal accounting officer, effective April 21, 2026. Mr. Pangburn has been with the company since February 2008, most recently as Senior Director—Assistant Controller since June 2025. Jessica L. Parrish, the previous Vice President—Chief Accounting Officer and Treasurer, will cease serving as principal accounting officer but continue as a Vice President in a different finance leadership role.

• ·Mr. Pangburn's prior roles: Senior Director—Assistant Controller (June 2025), Senior Director—Accounting (October 2023 to June 2025), Director—Accounting (June 2020 to October 2023).
• ·Filing signed on April 27, 2026.

27-04-2026

On April 23, 2026, Xencor, Inc. adopted the Executive Severance Policy applicable to certain executives, including named executive officers (NEOs) except the CEO, who must sign a participation agreement to be eligible. Outside a Change in Control Period, eligible NEOs receive 15 months of base salary and up to 15 months of COBRA premiums upon termination without Cause or resignation for Good Reason, subject to a release. During a Change in Control Period, additional benefits include 15 months of target bonus, a prorated annual bonus, and accelerated vesting of all outstanding unvested equity awards.

• ·Change in Control Period defined as three months prior to and 12 months following a change in control.
• ·Policy filed as Exhibit 10.1.
• ·NEOs must execute a general release for benefits to apply.

27-04-2026

agilon health (NYSE: AGL) appointed Tim O’Rourke as Chief Executive Officer and Board member effective May 7, 2026, succeeding Ronald A. Williams, who transitions from Executive Chairman (since August 2025) to continue as Chairman of the Board. The move follows operational and financial transformation, positioning the company to capitalize on value-based care demand with O’Rourke's 25+ years of payor and provider experience. agilon operates a platform with a peer network of approximately 2,300 primary care physicians across 30 communities.

• ·O’Rourke's prior roles: President of Help at Home; CEO of Ascension Complete; 17 years at Humana in Medicare Advantage and value-based care
• ·Ronald A. Williams served as Executive Chairman since August 2025
• ·Investor contacts: Evan Smith (SVP, Investor Relations), Megan Cagle

27-04-2026

On April 22, 2026, Max Brodén, a member of Trupanion's Board of Directors, notified the company that he will not stand for re-election at the 2026 Annual Stockholders’ Meeting on June 10, 2026, citing personal reasons with no disagreements with the company or Board; he will serve until the meeting. His departure does not impact the strategic partnership with Aflac, which remains committed. Trupanion filed its 2025 Annual Report, including a Shareholder Letter, on April 27, 2026.

• ·2026 Annual Meeting scheduled at 9 am Pacific Time on June 10, 2026
• ·Item 7.01 information furnished under Regulation FD, not deemed 'filed' for liability purposes

27-04-2026

On April 20, 2026, Brookfield Oaktree Holdings, LLC (BOH) entered into a Distribution Agreement with affiliate Brookfield Oaktree Holdings Canada Inc. (BOHCI), distributing 100 Common Shares of OCG NTR Holdings LLC (NTR), representing 100% of BOH's equity interests in NTR, via an in-kind distribution in respect of BOH's Class A common units. NTR indirectly holds 100% interests in entities including Brookfield Real Estate Income Trust Inc. The transaction was completed on the same date.

• ·Filing date: April 27, 2026
• ·BOHCI is an affiliate of Brookfield Corporation, sole holder of BOH’s Class A common units
• ·Distribution Agreement attached as Exhibit 10.1

27-04-2026

Martin Marietta Materials, Inc. (NYSE: MLM) announced the appointment of Christopher W. Samborski as Executive Vice President and Chief Operating Officer, effective May 1, 2026, following his successful leadership of the West and Specialties Divisions. Samborski, who joined the company in 2018 after roles at Caterpillar Inc. and Johnson & Johnson, was praised by Chair and CEO Ward Nye for his impact on operations and culture. Kirk Light has assumed leadership of the West and Specialties Divisions while retaining his Southwest Division role, amid the company's record 2025 results.

• ·Mr. Samborski's prior roles at Martin Marietta: President of Specialties Division (2022-2025), Vice President of Strategic Finance, Procurement and Supply Chain (2020-2021), Vice President of Strategic Finance (2018-2020).
• ·Martin Marietta operates in 28 states, Canada, and The Bahamas.

27-04-2026

Bentley Systems, Incorporated entered into a First Amendment and Incremental Facility Agreement dated April 23, 2026, establishing new First Incremental Term Commitments for up to $550,000,000 in Incremental Term Loans under its existing credit agreement originally dated October 18, 2024. The amendment was agreed upon by the Borrower, Subsidiary Loan Parties, PNC Bank as Administrative Agent, and First Incremental Term Lenders, with the loans to be repaid per the amended terms and maturing on the First Incremental Term Loan Maturity Date. Representations confirm no Defaults or Events of Default exist before or after the amendment, with pro forma compliance to covenants including a Net Senior Secured Leverage Ratio not exceeding the maximum permitted minus 0.25.

• ·Effective upon satisfaction of conditions including executed agreements, delivery of First Incremental Term Notes, officer certificates, legal opinion from Faegre Drinker Biddle & Reath LLP, lien searches, fees, insurance evidence, KYC documentation, and Borrowing Request.
• ·Pro forma as of December 31, 2025: compliance with Sections 6.12 and 6.13 covenants; Net Senior Secured Leverage Ratio ≤ Maximum Permitted Net Senior Secured Leverage Ratio minus 0.25.
• ·First Incremental Term Commitments terminate upon funding on First Amendment Effective Date.

27-04-2026

Charging Robotics Inc. announced the resignation of CEO Yakov Baranes effective May 1, 2026, for personal reasons with no disagreements on company matters; he will remain on the board. The company appointed Meni Nachmias, a senior executive with over 20 years of experience including roles in the Israeli Navy and Bullard Maritime Services, as the new CEO effective the same date. Nachmias' base salary is NIS 12,000 per month under an at-will agreement terminable with 30 days' notice.

• ·Nachmias holds MA in international relations and negotiation and BA in political science and human services from University of Haifa.
• ·No arrangement or understanding with other persons for Nachmias' appointment; no disclosable transactions under Item 404(a) of Regulation S-K.
• ·Company is an emerging growth company.

27-04-2026

Fossil Group, Inc. announced on April 24, 2026, that Joe Martin resigned as Chief Commercial Officer to pursue other interests, with his last day set for May 8, 2026. CEO Franco Fogliato will immediately assume Mr. Martin's responsibilities, leveraging his prior experience leading the commercial sales organization. The company has begun searching for a successor.

• ·The 8-K was filed on April 27, 2026.

27-04-2026

NVIDIA Corporation announced that Donald Robertson, VP and Chief Accounting Officer, will retire effective May 4, 2026, and remain as VP, Finance until July 1, 2026. The company appointed Scott Gawel, age 55 and formerly Corporate VP and CAO at Intel Corporation, as the new VP and CAO effective May 4, 2026, with an annual base salary of $800,000 and new hire RSUs valued at $12,875,000 vesting over four years. There are no related arrangements, transactions under Item 404(a) of Regulation S-K, or family relationships with directors or executives.

• ·Scott Gawel's prior roles: Corporate VP and CAO at Intel (2022-2026); Senior VP and Corporate Controller at Oracle (2020-2022); Senior VP and Assistant Controller at Oracle (2017-2020); VP, Corporate Accounting at Oracle (2009-2017); Senior Director, Corporate Accounting at Oracle (2004-2009).
• ·RSUs governed by NVIDIA's Amended and Restated 2007 Equity Incentive Plan.
• ·Scott Gawel eligible for standard employee benefits and will enter into the company's standard indemnity agreement.

27-04-2026

Andretti Acquisition Corp. II, a SPAC, entered into an Amended and Restated Promissory Note dated April 27, 2026, amending the original note from October 14, 2025, to provide working capital financing up to an unspecified Maximum Loan Amount prior to its Business Combination. The note is non-interest bearing, due upon Business Combination consummation or liquidation, with no fees on drawdowns and an optional conversion of unpaid principal into private placement units at $10.00 per unit for the Payee. No outstanding principal balance or drawn amounts are specified.

• ·Payee waives all claims against the Trust Account holding IPO proceeds.
• ·Note governed by Delaware law; no assignment by Maker without Payee consent.
• ·Registration rights for Conversion Units mirror the September 5, 2024 Registration Rights Agreement.

27-04-2026

On April 27, 2026, CDT Equity Inc. appointed Ulrik Olsen as a director and member of the Audit, Compensation, and Nominating and Corporate Governance Committees, filling a board vacancy following Freda Lewis-Hall's immediate resignation as director, Board chairperson, and committee chair/member for family health reasons, with no disagreements noted. Chele Chiavacci Farley was appointed as the new Board chairperson and Nominating Committee chairperson, stepping down as Audit Committee chairperson, while Simon Fry was named Audit Committee chairperson. Mr. Olsen, an experienced property executive, brings expertise from roles at Scarborough Group Limited, OB Energy, and Gull New Zealand, and the Company holds a 20% stake in Sarborg Limited where he owns approximately 7.84%.

• ·Ulrik Olsen has been a director of Scarborough Group Limited since 2017, managing director of OB Energy since 2018, and Chief Operating Officer of Gull New Zealand from 2015 to 2017.
• ·Board determined Ulrik Olsen meets independence requirements under Nasdaq and SEC standards.
• ·Ulrik Olsen will participate in the Company’s non-employee director compensation program; no family relationships or arrangements influencing his appointment.
• ·Freda Lewis-Hall's resignation effective immediately and not due to any disagreement with Company operations, policies, or practices.

27-04-2026

Chicago Mercantile Exchange Inc., a subsidiary of CME Group Inc., entered into Amendment No. 11 to its 364-day multi-currency revolving secured credit facility effective April 22, 2026, maintaining the facility at $7 billion (expandable to $10 billion) for liquidity support in events like clearing firm defaults or payment disruptions. The facility is collateralized by clearing firm guaranty fund contributions and performance bond assets, with a consolidated tangible net worth compliance requirement. No changes to key terms beyond the amendment are disclosed.

• ·Filing submitted on April 27, 2026, reporting event of April 22, 2026.
• ·Exhibit 10.1: Amendment No. 11 to Credit Agreement filed.

27-04-2026

T1 Energy Inc. announced the retirement of Chief Development Officer Einar Kilde effective April 22, 2026, with a separation agreement providing NOK 5.5 million severance paid in 12 installments, retention of 210,000 RSUs and options eligible to vest per the 2021 Equity Incentive Plan, and an expected 2025 bonus. On April 27, 2026, the company finalized employment terms for Chief Accounting Officer and Corporate Controller Tom Mahrer, including annual base salary, group bonus eligibility, equity awards, and customary benefits. No financial performance metrics were disclosed.

• ·Einar Kilde's options exercise period extended beyond the standard three-month post-employment period under the Plan.
• ·Tom Mahrer's appointment was previously disclosed in February 6, 2026 Form 8-K.
• ·Separation Agreement includes confidentiality, non-disparagement, and return of company property obligations.

27-04-2026

On April 22, 2026, the Compensation Committee of ParkerVision, Inc. approved modifications to outstanding nonqualified stock options held by CEO Jeffrey Parker (2,660,000 options) and CFO Cynthia French (870,550 options), extending the expiration date from August 7, 2026, to August 7, 2029, to preserve long-term incentive value. The options were awarded on August 7, 2019, at an exercise price of $0.171 per share and are fully vested. The company expects to record a one-time non-cash share-based compensation charge of approximately $360,000.

• ·Options awarded on August 7, 2019, with exercise price of $0.171 per share.
• ·No changes to exercise price, number of shares, vesting status, or other terms.
• ·Modification filed under Items 5.02(e) and 9.01 of Form 8-K on April 27, 2026.

27-04-2026

PACS Group, Inc. announced the planned retirement of co-founder and CFO Mark Hancock on June 30, 2026, who will transition to Vice Chairman of the Board; he will be succeeded by Carey P. Hendrickson as the new CFO. Under Hancock's leadership since 2013, the company grew from 2 facilities to 323 across 17 states, serving over 31,700 patients daily and achieving full-year 2025 revenue of $5.29 billion, up 29.3% YoY. The transition is framed positively with emphasis on Hancock's legacy and Hendrickson's extensive healthcare finance experience.

• ·Company founded in 2013 with 2 facilities in San Diego, CA.
• ·IPO on NYSE in April 2024.
• ·Hancock served as Interim CFO in September 2025.

27-04-2026

Matador Resources Company (NYSE: MTDR) announced leadership promotions effective April 21, 2026: Christopher P. Calvert to Executive Vice President and Chief Financial Officer from his prior role as EVP and COO, and Glenn W. Stetson to Executive Vice President and Chief Operating Officer from EVP – Production. Robert T. Macalik ceased serving as CFO on the same date, with no relation to financial, accounting issues, or disagreements with the company. The promotions are intended to strengthen focus on execution, efficiency, and long-term value creation, with both promotees having over 10 years at Matador and approximately 20 years of industry experience.

• ·Calvert joined Matador in October 2014
• ·Stetson joined Matador in August 2014
• ·Both served on Matador’s Executive Committee
• ·Operations focused on Wolfcamp and Bone Spring plays in Delaware Basin, Haynesville shale and Cotton Valley plays in Northwest Louisiana

27-04-2026

Charlton Aria Acquisition Corporation (Nasdaq: CHARU) announced that its Sponsor, ST Sponsor II Limited, deposited $850,000 into the trust account on April 24, 2026, extending the deadline to complete its initial business combination from April 25, 2026, to July 25, 2026. This represents the first of two possible three-month extensions, each requiring a $850,000 deposit, for a total potential of up to $1,700,000. The Company continues to seek a merger, share exchange, asset acquisition, or similar business combination without industry or geographic limitations.

• ·Original deadline: April 25, 2026 (18 months from IPO consummation)
• ·Contact: 221 W 9th St #848, Wilmington, DE 19801; Email: jmlee@charltonaria.com

27-04-2026

Profusa Inc. entered into an Asset Purchase Agreement dated April 21, 2026, with Bio Insights LLC to acquire substantially all know-how assets related to the PanOmics Platform, an integrated NGS multi-omics analysis platform for drug discovery and precision medicine, excluding patents and physical samples. In consideration, Profusa will issue Series A Convertible Preferred Stock to Bio Insights, convertible into common stock after one year subject to a 4.9% beneficial ownership limitation, with Seller granting a Sample Access License for up to [***] samples across two cohorts. The transaction follows due diligence and a non-binding Letter of Intent dated April 6, 2026, with no financial purchase price disclosed.

• ·No Patent Rights transferred; Seller retains all patents and rights to prosecute/maintain them.
• ·Sample Access License: Exclusive right to test up to [***] samples (Cohort 1: [***] samples deliverable within 30 Business Days post-Closing with [***] Consent Documentation; Cohort 2: [***] samples).
• ·Buyer assumes no liabilities of Seller.
• ·Shareholder Approval required for Nasdaq compliance (Rules 5635(a) and 5635(d)).

27-04-2026

On April 27, 2026, Splash Beverage Group, Inc. appointed Francis Knuettel II as a new director to its Board, effective immediately. Mr. Knuettel, experienced in CXO roles at early-stage public companies such as Pelthos Therapeutics Inc. (NYSE American: PTHS) and Unrivaled Brands, was also appointed to the Audit Committee, Compensation Committee, and Corporate Governance and Nominating Committee. There are no arrangements, family relationships, or disclosable transactions under Item 404(a) of Regulation S-K related to his appointment.

• ·Mr. Knuettel served as CFO of Pelthos Therapeutics Inc. from June 2022 to April 2026, CEO from July 2023 to July 2025, and director from August 2024 to July 2025.
• ·Prior to Pelthos, Mr. Knuettel was CEO and director of Unrivaled Brands from December 2020 to March 2022.

27-04-2026

Workhorse Group Inc. entered into Omnibus Amendment No. 1 with Motive GM Holdings II LLC, effective April 25, 2026, increasing the Cash Flow Credit Agreement commitment from $10,000,000 to $20,000,000 while reducing the Customer Order Credit Agreement commitment from $40,000,000 to $30,000,000. This doubles potential borrowing under the cash flow facility but cuts availability by 25% under the customer order facility. The amendment is subject to closing conditions including no default and reaffirmed representations and warranties.

• ·Interest on the $10,000,000 loan made on or about April 25, 2026, is due commencing after September 30, 2026.
• ·Amendment effective upon execution, no Event of Default, and reaffirmed representations and warranties.
• ·Governed by New York law; constitutes a Loan Document.

27-04-2026

LSB Industries, Inc.'s Compensation Committee approved a one-time retention grant of 706,880 restricted stock units (RSUs) to Chairman, President, and CEO Mark T. Behrman on April 24, 2026, under the 2025 Long-Term Incentive Plan, vesting on March 31, 2029, subject to continued service. The award includes dividend equivalents and accelerated vesting provisions for certain terminations like qualifying separation, death, or disability, but forfeiture in specific change-of-control scenarios. It aims to align executive interests with shareholders and incentivize company growth.

• ·RSUs represent right to one share of common stock or cash equivalent upon vesting.
• ·Full vesting acceleration on Qualifying Separation from Service (not in connection with change in control).
• ·Pro-rata vesting on death or disability prior to change in control.
• ·Forfeiture if Qualifying Separation occurs with change in control triggering employment agreement benefits.

27-04-2026

AB Private Credit Investors Corp and multiple affiliated AB-Abbott private equity and credit funds entered into the Nineteenth Amendment to their Revolving Credit Agreement, originally dated June 14, 2019, with HSBC Bank USA, National Association as administrative agent and lenders, effective April 22, 2026. The amendment modifies certain sections and schedules of the Credit Agreement upon satisfaction of conditions including execution by parties, beneficial ownership certifications, and payment of fees to the agent and its counsel. No specific financial terms, changes in commitments, or performance metrics are disclosed in the filing.

• ·Amendment is the 19th since original Credit Agreement dated June 14, 2019
• ·Conditions precedent include executed counterparts, Beneficial Ownership Certifications, and payment of fees including to Cadwalader, Wickersham & Taft LLP
• ·Governed by laws of the State of New York

27-04-2026

Sallie Mae (Nasdaq: SLM), formally SLM Corporation, announced the appointment of Chief Financial Officer Peter Graham and Chief Operational Officer Kerri Palmer as Co-Presidents, reporting to CEO Jon Witter, following the retirement of the Chief Commercial Officer. Graham will continue as CFO while overseeing strategic partnerships and emerging lines of business; Palmer will lead as Head of Financial Services, including the core private education loan business, credit, and operations. The appointments reflect the company's commitment to leadership depth and execution of its disciplined growth strategy amid strong performance.

• ·Graham has served as Executive Vice President and CFO since 2023, overseeing finance, accounting, treasury, and investor relations.
• ·Palmer has served as Executive Vice President, COO, and President of Sallie Mae Bank since 2023; previously Chief Risk Officer and Chief Risk and Compliance Officer.
• ·Appointments effective as of April 27, 2026 announcement.